EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:754310 |
| ChEBI Name | alirocumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | anticholesteremic drug A substance used to lower plasma cholesterol levels. hypoglycemic agent A drug which lowers the blood glucose level. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| alirocumab (CHEBI:754310) has role antiatherosclerotic agent (CHEBI:145947) |
| alirocumab (CHEBI:754310) has role anticholesteremic drug (CHEBI:35821) |
| alirocumab (CHEBI:754310) has role cardiovascular drug (CHEBI:35554) |
| alirocumab (CHEBI:754310) has role hypoglycemic agent (CHEBI:35526) |
| alirocumab (CHEBI:754310) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Alirocumab | ChEMBL |
| REGN-727 | ChEMBL |
| REGN727 | ChEMBL |
| SAR-236553 | ChEMBL |
| SAR236553 | ChEMBL |
| Brand Name | Source |
|---|---|
| Praluent | ChEMBL |